Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance
Inflammatory Bowel Diseases · 2024
DOI: 10.1093/ibd/izae042 ↗Kurz gefasst
Leserbrief in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Sem Geertsema und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
- Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
ORCID-Profile: Arno R Bourgonje
Zitieren
APA
Geertsema, S., Fagundes, R. R., Otten, A. T., Dijkstra, G., Faber, K. N., & Bourgonje, A. R. (2024). Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae042
Vancouver
Geertsema S, Fagundes RR, Otten AT, Dijkstra G, Faber KN, Bourgonje AR. Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izae042
BibTeX
@article{Geertsema2024,
author = {Geertsema, Sem and Fagundes, Raphael R and Otten, Antonius T and Dijkstra, Gerard and Faber, Klaas Nico and Bourgonje, Arno R},
title = {Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance},
journal = {Inflammatory Bowel Diseases},
year = {2024},
doi = {10.1093/ibd/izae042}
}
EUVIMED